Literature DB >> 8088763

Growth factors in monoclonal light-chain--related renal diseases.

G A Herrera1, J J Shultz, S J Soong, P W Sanders.   

Abstract

The immunomorphological expressions of monoclonal light-chain-related renal diseases (MLCRRD) are extremely varied but have a common pathogenetic feature: monoclonal light-chain deposition. The underlying cellular events involved in these processes are likely a reflection of interactions of a complex cascade of inciting and modulating factors. This study explored the potential role of growth factors in MLCRRD by examining the expression of insulin-like growth factor (IGF-I), fibroblast growth factor (FGF), transforming growth factor-beta (TGF-beta), and platelet-derived growth factor A chain (PDGF-A) and B chain (PDGF-B) in 36 cases of MLCRRD. All growth factors examined were expressed in tubules, primarily proximal, but to varying extent. Intensity of IGF-I and TGF-beta tubular staining correlated with tubular injury and interstitial fibrosis. Intensity of tubular staining with antibodies to FGF also correlated with interstitial fibrosis. Platelet-derived growth factor B chain was strongly detected in glomeruli and, in some cases, in vascular structures. Transforming growth factor-beta was detected only in glomeruli of three patients with nodular glomerulopathy associated with light-chain-deposition disease. Insulin-like growth factor, FGF, and PDGF-A were not detected in glomeruli or vessels in any of the cases. Proliferating cell nuclear antigen (PCNA) staining in tubules and glomeruli was markedly increased in light-chain-deposition disease and less but still significantly increased above control values in the other variants of MLCRRD. These results suggested: (1) a correlation between IGF-I and TGF-beta staining in the tubular interstitium and tubular damage; (2) a correlation between IGF-I, TGF-beta, and FGF staining in the tubular interstitium and interstitial fibrosis; (3) a likely important role for PDGF-B activation in certain glomerular alterations that occur in MLCRRD; (4) a role for TGF-beta in light-chain-deposition disease; and (5) the presence of a significant proliferation signal in all cases of MLCRRD but most notably in light-chain-deposition disease in glomerular and tubular compartments. A cascade of events related to growth factor activation appears to play a fundamental role in the pathophysiological processes governing MLCRRD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088763     DOI: 10.1016/0046-8177(94)90007-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Expression of basic fibroblast growth factor in rat liver fibrosis and hepatic stellate cells.

Authors:  Xiaodong Peng; Bo Wang; Tancai Wang; Qiu Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  Pathophysiology and management of monoclonal gammopathy of renal significance.

Authors:  Ankur Jain; Richard Haynes; Jaimal Kothari; Akhil Khera; Maria Soares; Karthik Ramasamy
Journal:  Blood Adv       Date:  2019-08-13

Review 3.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

4.  Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.

Authors:  L Zhu; G A Herrera; J E Murphy-Ullrich; Z Q Huang; P W Sanders
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

5.  Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling.

Authors:  Guillermo A Herrera; Luis Del Pozo-Yauner; Jiamin Teng; Chun Zeng; Xinggui Shen; Takahito Moriyama; Veronica Ramirez Alcantara; Bing Liu; Elba A Turbat-Herrera
Journal:  Kidney Int Rep       Date:  2021-03-13

Review 6.  The pathogenesis of renal injury and treatment in light chain deposition disease.

Authors:  Qi Wang; Fang Jiang; Gaosi Xu
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.